Devra Olson

Devra Olson is a Principal Scientist at Pfizer since December 2023, located in Bothell, Washington. Prior experience includes serving as a Senior Scientist at Seagen from September 2013 to February 2024, where contributions were made toward innovative antibody-based cancer therapies. Devra Olson also held positions as an Associate Scientist at Ricerca Biosciences from April 2005 to December 2010, focusing on surgical research and disease models, and as a Research Associate and Study Coordinator at PhaseRx from January 2011 to July 2013, with a focus on RNAi therapeutics for liver cancer. Earlier in the career, Devra Olson worked as an Assistant Research Scientist at the University of Washington from 2001 to 2005, supporting research in the Department of Comparative Medicine, while also completing a degree in Zoology and Biology at the same institution from 1999 to 2004.